Patents by Inventor Junwei XI

Junwei XI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tricyclic compounds for the treatment of cancer
    Patent number: 12247036
    Abstract: The present invention relates to compounds of formula (Ib), wherein R1 to R3, M and L are as described herein, and their pharmaceutically acceptable salt, enantiomers and diastereomers thereof, and compositions including the compounds and methods of using the compounds.
    Type: Grant
    Filed: August 22, 2024
    Date of Patent: March 11, 2025
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Jianguo Chen, Lei Guo, Haixia Liu, Hong Shen, Junwei Xi, Weixing Zhang, Dan Zhao, Wei Zhu
  • TRICYCLIC COMPOUNDS FOR THE TREATMENT OF CANCER
    Publication number: 20240417410
    Abstract: The present invention relates to compounds of formula (Ib), wherein R1 to R3, M and L are as described herein, and their pharmaceutically acceptable salt, enantiomers and diastereomers thereof, and compositions including the compounds and methods of using the compounds.
    Type: Application
    Filed: August 22, 2024
    Publication date: December 19, 2024
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Jianguo CHEN, Lei GUO, Haixia LIU, Hong SHEN, Junwei XI, Weixing ZHANG, Dan ZHAO, Wei ZHU